- Eli Lilly Reaches $1 Trillion Market Cap on Booming Weight-Loss Drugs The Wall Street Journal
- Eli Lilly, Drug Maker of Zepbound and Mounjaro, Reaches $1 Trillion in Value The New York Times
- Lilly becomes first drugmaker to hit $1 trillion valuation on weight-loss demand Reuters
- Eli Lilly hits $1 trillion market value, a first for a health-care company CNBC
- Is GLP-1 the new AI? Drugmaker Eli Lilly joins the $1 trillion market-cap club. MarketWatch
Source link